Eli Lilly (LLY) Other Non-Current Assets (2009 - 2026)
Eli Lilly's Other Assets was $7.7 billion in Q3 2026, up 19.6% from $6.43 billion a year earlier and up 2.8% from the prior quarter.
Powered by 
Analysis
Eli Lilly (LLY) Other Non-Current Assets (2009 - 2026) Analysis & Trends
At the end of FY2025, Other Assets at Eli Lilly came in at $6.99 billion, up 22.2% from FY2024.
- Other Assets has now increased for six consecutive years, with a five-year compound annual growth rate of 15.0% (FY2020 to FY2025).
- In earlier years, Other Assets was $5.72 billion in FY2024 (+14.6%), $4.99 billion in FY2023 (+15.1%), $4.34 billion in FY2022 (+6.2%) and $4.08 billion in FY2021 (+17.5%).
- The Q3 2026 figure marks the highest quarterly Other Assets since Q4 2018.
- Compared with a year earlier, Other Assets has increased for 27 straight quarters, with growth averaging 22.2% over the last eight quarters.
- Over the past five years, the year-over-year growth in Other Assets ranged from 4.3% (Q3 2024) to 29.0% (Q1 2025).
- Per Business Quant data, LLY's Other Assets in the three quarters before Q3 2026 was $7.48 billion (Q2 2026), $7.23 billion (Q1 2026) and $6.99 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 7.70 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 15.10 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 9.42 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 19.90 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 700.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 14.60 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 4.90 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 10.02 Bn |
| 10 | Vertex Pharmaceuticals | 138.90 Bn | 106.64 Bn | 2.91 Bn | 1.31 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 7.70 Bn |
| Jun 30, 2026 | 7.48 Bn |
| Mar 31, 2026 | 7.23 Bn |
| Dec 31, 2025 | 6.99 Bn |
| Sep 30, 2025 | 6.43 Bn |
| Jun 30, 2025 | 6.23 Bn |
| Mar 31, 2025 | 6.07 Bn |
| Dec 31, 2024 | 5.72 Bn |
| Sep 30, 2024 | 5.12 Bn |
| Jun 30, 2024 | 4.90 Bn |
| Mar 31, 2024 | 4.71 Bn |
| Dec 31, 2023 | 4.99 Bn |
| Sep 30, 2023 | 4.91 Bn |
| Jun 30, 2023 | 4.67 Bn |
| Mar 31, 2023 | 4.49 Bn |
| Dec 31, 2022 | 4.34 Bn |
| Sep 30, 2022 | 4.54 Bn |
| Jun 30, 2022 | 4.47 Bn |
| Mar 31, 2022 | 4.29 Bn |
| Dec 31, 2021 | 4.08 Bn |
API Access
Eli Lilly Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=LLY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "LLY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=LLY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();